Prolonged progestin (quingestanol) therapy of menopausal diabetic women.
D015062:11-Hydroxycorticosteroids / Q000097:blood; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000368:Aged; D003350:Cortodoxone / Q000652:urine; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004967:Estrogens / Q000652:urine; D005260:Female; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000097:blood; D008593:Menopause; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D009649:Norpregnadienes / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood; D013997:Time Factors
D015062:11-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D007328:Insulin; D009649:Norpregnadienes; D007986:Luteinizing Hormone; D013006:Growth Hormone; D012964:Sodium; D003350:Cortodoxone; D008797:Metyrapone